Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Purity | ≥98% |
|---|---|
| Formula | C18H18O4 |
| Formula Wt. | 298.33 |
| IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
| Appearance | White Crystal Powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
Non-nucleoside RT inhibitor.
Iridoid glucoside found in Cornus officialis; Î...
NSAID; COX-1/2 inhibitor.
p110α and p110γ PI3K inhibitor.
Peptide; fibrinolysis inhibitor.
Imidazole; 14-α demethylase inhibitor.
Antimicrobial peptide found in Trichoderma, ind...
Naturally sourced ITC, sulfonyl analog of sulfo...
Inhibitor of glutamic acid decarboxylase (GAD)....
Inhibitor of CDK.
Selective CDK2 inhibitor.
Tricyclic benzonaphthyridinone; mTORC1/2 inhibi...
Synthetis peptide, melanocortin analog; MCR ago...
FAAH inhibitor.
Selective cannabinoid receptor 2 (CB2) inverse ...
Mixture of glycopeptide bleomycin sulfate salts...
NSAID; COX-1/2 and PDE inhibitor.
Cysteine-ITC conjugate, BITC derivative, antiox...
Natriuretic, vasodilatory peptide fragment; B1/...
NSAID; COX-2 inhibitor.